1 2 3 4 5 Next
Solexa and New England Biolabs Announce Enzyme Supply Agreement
HAYWARD, Calif. & CAMBRIDGE, England & IPSWICH, Mass.----Aug. 1, 2006--Solexa, Inc. today announced that it has reached an agreement with New England Biolabs Inc. , a leading supplier of enzymes and technologies to the life science market, for NEB to provide Solexa with certain key enzymes and other reagents for use with the Solexa Genome Analysis System. (Tue, 01 Aug 2006 04:01:00 GMT)
Geisinger joins research network
DANVILLE — Geisinger Health System was recently elected into the HMO Research Network, a national group that aims to shape health and health care delivery. (Tue, 01 Aug 2006 04:11:34 GMT)
Solexa and New England Biolabs Announce Enzyme Supply Agreement; New England Biolabs to Manufacture Key Polymerase for
Solexa, Inc. (9645;Nasdaq:SLXA) today announced that it has reached an agreement with New England Biolabs (Tue, 01 Aug 2006 04:20:01 GMT)
TCS to offer software solutions to US-based Sequenom Inc
Mumbai, Jul 31: In a major overseas deal, Indian software major Tata Consultancy Services (TCS) will offer software solutions to support next generation software tools of Sequenom Inc, the California-based provider of genetic analysis solutions. (Tue, 01 Aug 2006 05:51:11 GMT)
Bruker Daltonics And Isis Pharmaceuticals Enter Into Manufacturing And Distribution Agreement For Ibis T5000 Biosensor
Bruker Daltonics, a subsidiary of Bruker BioSciences (Nasdaq: BRKR), andIsis Pharmaceuticals (Nasdaq: ISIS) announce today a strategic alliance formanufacturing and distribution of Isis' Ibis T5000(TM) biosensor system. [click link for full article] (Tue, 01 Aug 2006 07:18:25 GMT)
UKPMC to launch online medical research archive
Scientists will be able to access biomedical research for free using technology by UK PubMed Central (UKPMC). (Tue, 01 Aug 2006 10:02:48 GMT)
Timing Of Food Consumption Activates Genes In Specific Brain Area
Giving up your regular late-night snack may be hard, and not just because it's a routine. The habit may genetically change an area of the brain to expect the food at that time, researchers at UT Southwestern Medical Center have discovered. By training mice to eat at a time when they normally wouldn't, the researchers found that food turns on body-clock genes in a particular area of the brain. (Tue, 01 Aug 2006 10:10:07 GMT)
Matritech Reports Second Quarter 2006 Financial Results
NEWTON, Mass.----Aug. 1, 2006--Matritech NPM22® BladderChek® Test Sales Increase of 20% over 2005 American Cancer Society Journal Article Reported NPM22® BladderChek® Test Can Save Lives and Reduce Expense Screening High Risk Populations for Bladder Cancer Sales to Gynecologists in Germany Continue to Grow and Exceed $1.2 Million Annualized Rate Company Revises 2006 Financial Guidance to $12 (Tue, 01 Aug 2006 11:00:00 GMT)
Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement with Bruker Daltonics
SAVANNAH, Ga.----Aug. 1, 2006--Health Discovery Corporation today announced that it has executed a non-exclusive worldwide license agreement with Bruker Daltonics Inc. covering Bruker Daltonics' use of HDC's Support Vector Machine technology in the ClinProTools clinical proteomics product line. (Tue, 01 Aug 2006 11:00:00 GMT)
Galapagos Licenses MetaCore From GeneGo
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that Galapagos NV, a genomics-based drug discovery company, will be using the integrated software suite MetaCore for its internal research across several disease areas including osteoporosis, osteoarthritis and rheumatoid arthritis. (Tue, 01 Aug 2006 12:00:00 GMT)
2,000 Lost Boys with Duchenne Muscular Dystrophy
London, UK (PRWEB) August 1, 2006 -- Parent Project UK is pleased to announce that VASTox plc, a leading chemical genomics company, announces today it has provided a £20,000 grant to the UK muscular dystrophy charity. (Tue, 01 Aug 2006 12:00:00 GMT)
We’re looking for the best researchers
Macquarie University is embarking on an in-vestment plan to ensure our pre-eminence in a range of research areas of international significance and benefit to Australia. (Tue, 01 Aug 2006 12:09:50 GMT)
Med Biogene Inc. receives renewed ethics board approval from Vancouver Coastal Health Authority; expects to release
Med BioGene Inc. is pleased to announce that it has received renewed ethics board approval from the Vancouver Coastal Health Authority. MBI received initial ethics board approval in June 2005. (Tue, 01 Aug 2006 12:30:00 GMT)
MedQuist Licenses Healthcare De-Identification Software
De-identification of medical records and reports is a critical success factor in the creation of new quality reporting solutions and the capacity for healthcare providers to conduct population-based data mining. (Tue, 01 Aug 2006 13:00:00 GMT)
New Research Reports Focus Attention on Power3 Medical Products
HOUSTON----Aug. 1, 2006--New independent research reports have once again focused attention on Power3 Medical Products, Inc. , a leading proteomics company that develops and commercializes early detection diagnostic tests for breast cancer and neurodegenerative diseases. (Tue, 01 Aug 2006 13:40:00 GMT)
Expression Analysis Signs New Agreement to Provide Genotyping Services to GlaxoSmithKline
DURHAM, N.C.----Aug. 1, 2006--Expression Analysis, Inc. a full-service microarray processing, analysis and data management organization, has entered into an agreement with GlaxoSmithKline to provide microarray based genotyping services. (Tue, 01 Aug 2006 15:00:00 GMT)
National Oceanic and Atmospheric Administration Licenses the Rosetta Resolver Gene Expression Data Analysis System
SEATTLE & WASHINGTON----Aug. 1, 2006--Rosetta Biosoftware announced today that the National Oceanic and Atmospheric Administration has purchased a license for its Rosetta Resolver® system to conduct research on the toxicogenomic response of animal models and protected marine species to marine biotoxins. (Tue, 01 Aug 2006 15:00:00 GMT)
University Of Pennsylvania Researchers Find Role For MicroRNAs In Oxygenation, Nourishing Of Colon Tumors
Researchers from the University of Pennsylvania School of Veterinary Medicine have identified how molecules of microRNA are responsible for the growth of blood vessels in a model for human colon cancer (Tue, 01 Aug 2006 15:11:58 GMT)
Affymetrix shares slump to lowest level in more than 3 years
SAN FRANCISCO (MarketWatch) -- Shares of Affymetrix Inc. plunged 19% to their lowest point in more than three years on Tuesday after the maker of genomics tools reported lower revenues and said it swung to a loss in the second quarter, hurt by a spike in costs. (Tue, 01 Aug 2006 16:10:24 GMT)
MedQuist Licenses Healthcare De-Identification Software
De-identification of medical records and reports is a critical success factor in the creation of new quality reporting solutions and the capacity for healthcare providers to conduct population-based data mining. In support of these goals, MedQuist Inc. (Pink Sheets: MEDQ), the world's premier medical transcription service provider and a leader in innovative health information management (Tue, 01 Aug 2006 17:05:38 GMT)
Expression Analysis Lands Contract With GSK For Genotyping Services
DURHAM, N.C. – Expression Analysis has landed a contract with GlaxoSmithKline to provide the pharmaceutical giant with microarray-based genotyping services. (Tue, 01 Aug 2006 18:08:39 GMT)
IBC Announces Keynote and Session Lineup for Assays & Cellular Targets (ACT) Conference & Exhibition
IBC announced today the keynote presenterlineup and conference agenda for its upcoming Assays & Cellular Targets(ACT) 2006 conference, to be held October 30 - November 1 at the GreenValley Ranch Resorts in Las Vegas, NV. The conference provides learningand networking opportunities for discovery groups, assay developers,screeners and technology innovation groups in pharmaceutical andbiotechnology (Tue, 01 Aug 2006 18:23:41 GMT)
Gene Logic Restructures Genomics Division
GAITHERSBURG, Md.----Aug. 1, 2006--Gene Logic Inc. announced today that it has initiated a plan to reduce the number of employees in its Genomics Division and related Corporate staff by eliminating approximately 80 positions, effective October 5, 2006. (Tue, 01 Aug 2006 20:15:00 GMT)
Affymetrix shares slump to 3-year low after the genomics toolmaker reported lower revenues and said it swung to a loss
Affymetrix shares slump to 3-year low after the genomics toolmaker reported lower revenues and said it swung to a loss due to a spike is cost and lower productivity. (Tue, 01 Aug 2006 20:41:55 GMT)
Gene Logic to Cut 80 Jobs
Gene Logic Inc., which provides genetic testing services to drug makers, on Tuesday said it will cut about 80 jobs in the restructuring of its genomics division. (Tue, 01 Aug 2006 21:26:03 GMT)
Gene Logic to lay off 80
Gene Logic will cut 80 people in its genomics division and related corporate staff starting this fall, the company announced late Tuesday afternoon. (Tue, 01 Aug 2006 23:11:44 GMT)
GeneLogic to cut 80 jobs
Three days prior to its second quarter earnings conference call, bioscience company GeneLogic Inc. of Gaithersburg reports that it is eliminating 80 jobs in its genomics division and related administrative staff. (Tue, 01 Aug 2006 23:24:33 GMT)
TCS to develop Life Science software for Sequenom
Sequenom, a provider of genetic analysis solutions for epigenetic analysis, fine mapping, and molecular medicine, announced that it has come to an agreement with Tata Consultancy Services (TCS), a global technology services and consulting company, to develop software solutions that will support Sequenom''s next generation of software tools and enable the delivery of greatly expanded functionality (Wed, 02 Aug 2006 04:21:20 GMT)
Matritech's NMP22(R) BladderChek(R) Test Can Save Lives And Reduce Expense Screening High Risk Populations For Bladder
An article published in an early online view of the American Cancer Society's journal Cancer reports that screening for bladder cancer in high risk populations can save lives and reduce overall medical expenses. All other cancer screening programs save lives but increase expenses. Screening for bladder cancer with the NMP22(R) BladderChek(R) Test was less costly than not screening. [click link (Wed, 02 Aug 2006 07:22:27 GMT)
Illumina Expands Services Agreement with GlaxoSmithKline to Include Infinium(TM) Genotyping with HumanHap550 BeadChips
SAN DIEGO----Aug. 2, 2006--Illumina, Inc. announced today that it has expanded the scope of its multi-year, genotyping services agreement with GlaxoSmithKline . Under the terms of the new agreement, Illumina will begin to use Sentrix® HumanHap550 BeadChips for a series of whole-genome association studies for GSK. (Wed, 02 Aug 2006 10:00:00 GMT)
Genetic Research Reinforces Theory Of Evolution
Scientists led by a Children's Hospital of Pittsburgh geneticist have found new evidence that a category of genes known as pseudogenes serve no function, an important finding that bolsters the theory of evolution. (Wed, 02 Aug 2006 10:24:31 GMT)
Affymetrix Control Program Advances Association Studies and Saves Researchers Time and Money
SANTA CLARA, Calif.----Aug. 2, 2006--Affymetrix Inc. announced today that it is collaborating with leading researchers around the world as part of the Affymetrix Control Program. The program will provide free, public access to control cohort data for whole-genome association studies using Affymetrix GeneChip® genotyping arrays. (Wed, 02 Aug 2006 12:00:00 GMT)
Gene Logic to Lay Off 80 as Part of Genomics Division Restructuring
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click . (Wed, 02 Aug 2006 14:05:40 GMT)
New Paradigm Will Help Identify Leads For Drug Discovery
A new screening approach can profile compounds in large chemical libraries more accurately and precisely than standard methods, speeding the production of data that can be used to probe biological activities and identify leads for drug discovery, the National Institutes of Health (NIH) Chemical Genomics Center, part of the NIH Roadmap for Medical Research's Molecular Libraries and Imaging (Wed, 02 Aug 2006 14:36:55 GMT)
Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement With Bruker Daltonics
Health Discovery Corporation ("HDC") announced that it has executed a non-exclusive worldwide license agreement with Bruker Daltonics Inc. covering Bruker Daltonics' use of HDC's Support Vector Machine ("SVM") technology in the ClinProTools clinical proteomics product line (Wed, 02 Aug 2006 14:40:35 GMT)
SRU Biosystems Able to Conduct Business
SRU Biosystems, Inc. announced today that in connection with the patent litigation brought by Corning Incorporated and Artificial Sensing Instruments ASI AG, the United States District Court for the District of Delaware has resolved in SRU's favor a months-long dispute over the content and scope of a permanent injunction order sought by Corning. (Wed, 02 Aug 2006 16:00:00 GMT)
British Library-led Partnership Chosen To Run UK PubMed Central
Scientists will be able to access a vast collection of biomedical research at the touch of a button thanks to a major new initiative that aims to promote the free transfer of ideas in a bid to speed up scientific discovery. (Wed, 02 Aug 2006 16:03:51 GMT)
Research and Markets: 20,180 New Cases of Ovarian Cancer will be Diagnosed this Year in the United States
DUBLIN, Ireland----Aug. 2, 2006--Research and Markets has announced the addition of the Decision Resources report: Emerging Diagnostic Biomarkers in Ovarian Cancer to their offering. (Wed, 02 Aug 2006 16:50:00 GMT)
SuperArray Bioscience Releases Over 36 Pathway-Focused Real-Time PCR Gene Panels for All Stages of Drug Discovery and
SuperArray Bioscience announced today that it will feature its real-time RT2Profiler PCR Arrays at the upcoming Drug Discovery Technology meeting at the Boston World Trade Center and Seaport Hotel from August 8 to 10. (Wed, 02 Aug 2006 17:29:00 GMT)
Gene test gives key to Darwinian evolution of finch beaks
Scientists have discovered the reason for a phenomenon that supported Charles Darwin's theory of evolution -- the varied shape of finches' beaks -- according to the journal Nature. (Wed, 02 Aug 2006 18:56:41 GMT)
U.S. Department of Energy to invest $250 million in new bioenergy centers - Basic genomics research on the development
U.S. Department of Energy (DOE) Secretary Samuel W. Bodman announced today that DOE will spend $250 million to establish and operate two new Bioenergy Research Centers to accelerate basic research on the development of cellulosic ethanol and other biofuels. (Wed, 02 Aug 2006 19:45:23 GMT)
SRU Biosystems OK'd to conduct business
SRU Biosystems announces the United States District Court for the District of Delaware has resolved in SRU's favor a dispute over the content and scope of a permanent injunction order sought by Corning. (Wed, 02 Aug 2006 20:37:13 GMT)
SuperArray Bioscience Releases Over 36 Pathway-Focused Real-Time PCR Gene Panels for All Stages of Drug Discovery and
SuperArray Bioscience (http://www.superarray.com/) announced today that it will feature its real-time RT2Profiler(TM) PCR Arrays at the upcoming Drug Discovery Technology meeting at the Boston World Trade Center and Seaport Hotel from August 8 to 10. The RT2Profiler(TM) PCR Arrays now encompass over 36 different human and mouse pathways or disease states. In these PCR Arrays, SuperArray has (Wed, 02 Aug 2006 21:50:50 GMT)
Device Can "Battle" Hospital Infections
An innovative University at Buffalo air sterilization technology that the U.S. Department of Defense is funding to protect troops on the battlefield soon may protect hospital patients from deadly infections, thanks to recent funding from the New York State Office of Science, Technology and Academic Research (NYSTAR). (Wed, 02 Aug 2006 23:15:19 GMT)
Alpha Innotech Reports 27% Second Quarter Revenue Growth
SAN LEANDRO, Calif.----Aug. 2, 2006--Alpha Innotech Corp. , a leading provider of bioanalytical systems for drug discovery and life science research, today reported financial results for the second quarter ending June 30, 2006. (Thu, 03 Aug 2006 00:29:00 GMT)
TeAM: Bioinformatics to spawn innovation
Bioinformatics, the point of convergence between biotechnology and ICT (information and communications technology) will spark off a new era in ICT innovation and business opportunities for Malaysian technopreneurs, said the Technopreneurs Association of Malaysia (TeAM). (Thu, 03 Aug 2006 00:49:12 GMT)
Role For MicroRNAs In Angiogenesis Found By Penn Researchers
Researchers from the University of Pennsylvania School of Veterinary Medicine have identified how molecules of microRNA are responsible for the growth of blood vessels in a model for human colon cancer. The process, called angiogenesis, results in ability of ravenous cancer cells to recruit blood vessels and receive a steady supply of nutrients and oxygen. [click link for full article] (Thu, 03 Aug 2006 01:15:45 GMT)
Hawaii gets $19 million for oceanography center
A new $19 million federal grant will help fund a University of Hawaii-led center focusing on the study of microscopic organisms in the world's oceans. (Thu, 03 Aug 2006 06:51:11 GMT)
SuperArray Bioscience Releases Over 36 Pathway-Focused Real-Time PCR Gene Panels For All Stages Of Drug Discovery And
SuperArray Bioscience(http://www.SuperArray.com) announced today that it will feature itsreal-time RT2Profiler(TM) PCR Arrays at the upcoming Drug DiscoveryTechnology meeting at the Boston World Trade Center and Seaport Hotel fromAugust 8 to 10. The RT2Profiler(TM) PCR Arrays now encompass over 36different human and mouse pathways or disease states. [click link for full article] (Thu, 03 Aug 2006 07:23:03 GMT)
Piribo: Cytogenetics – the Next Big Thing?
Piribo, [www.piribo.com] the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report entitled “Cytogenetics Technologies, markets and companies.” (PRWEB Aug 3, 2006) Trackback URI: http://www.prweb.com/zingpr.php/U2luZy1GYWx1LU1hZ24tSW5zZS1JbnNlLVplcm8= (Thu, 03 Aug 2006 07:28:13 GMT)
Applied Biosystems and GeneGo Collaborate to Advance Understanding of Tissue Gene Expression
FOSTER CITY, Calif. & St. Joseph, Mich.----Aug. 3, 2006--Applied Biosystems , an Applera Corporation business, and GeneGo, Inc., a leading provider of software and databases for systems biology, today announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways. (Thu, 03 Aug 2006 11:00:00 GMT)
Cell Signaling Technology Demonstrates the Discovery Capabilities of its PhosphoScan(R) Proteomics Platform with
DANVERS, Mass.----Aug. 3, 2006--Cell Signaling Technology, Inc. announced today the publication of discovery research based on its patent-pending PhosphoScan® proteomics technology, which identified a mutant JAK3 tyrosine kinase as a novel driver in acute myeloid leukemia . (Thu, 03 Aug 2006 12:00:00 GMT)
Piribo: Cytogenetics – the Next Big Thing?
(PRWEB) August 3, 2006 -- Piribo, [www.piribo. (Thu, 03 Aug 2006 12:00:00 GMT)
Nanogen and Fisher Scientific Expand Molecular Diagnostics R&D Collaboration Agreement
SAN DIEGO and HAMPTON, N.H., Aug. 3 /PRNewswire-FirstCall/ -- Nanogen, ( Nachrichten ) Inc. , a developer of advanced diagnostic products, and Fisher Scientific International ( Nachrichten ) Inc. announced today that the companies have expanded their relationship to include a research and development collaboration in molecular diagnostics. (Thu, 03 Aug 2006 12:14:02 GMT)
Med BioGene reports promising pre-clinical results of its Diagnostic Lymphoma DNA Bioarray; biomarkers effective in
Med BioGene Inc. is pleased to announce the results of its pre-clinical studies involving its Diagnostic Lymphoma Bioarray. The studies of fifty RNA samples derived from human lymphoma tissues suggest that MBI's Diagnostic Lymphoma Bioarray successfully differentiated between genes in both the diseased and healthy control samples. (Thu, 03 Aug 2006 12:30:00 GMT)
FierceMarkets Launches FierceBioResearcher
WASHINGTON, Aug. 3, 2006 (PRIMEZONE) -- In an expansion of its commitment to serving the biotech industry, FierceMarkets (www.fiercemarkets.com) today launched a new informational resource called FierceBioResearcher (http://www.fiercebioresearcher.com). Published every Thursday, the weekly newsletter and complementary Web site provide a one-stop source of critical news and information for (Thu, 03 Aug 2006 13:00:00 GMT)
Biomatters ships Geneious Pro 2.01
Biomatters has introduced Geneious Pro 2.01, a software solution that incorporates collaboration, sequence alignment editing and ClustalW to make bioinformatics easier for all scientists. Geneious is a self-organizing, automatically-updating library ... (Thu, 03 Aug 2006 14:29:29 GMT)
JS-Sorcerer(TM) Accelerates Research at University of Connecticut Health Center
RENTON, Wash.----Aug. 3, 2006--DHI Technologies, Inc., today announced that JS-Sorcerer helped create a cross-browser JavaScript application for scientists at the UConn Proteomics and Biological Mass Spectrometry Lab. (Thu, 03 Aug 2006 15:00:00 GMT)
Device could do "battle" with hospital infections
An innovative UB air-sterilization technology that the U.S. (Thu, 03 Aug 2006 15:03:37 GMT)
Study focuses on brain receptor in cognitive disorders
Only one drug is approved to treat persons with mild to moderate Alzheimer's symptoms, despite the fact that the brain protein at the core of this disease, the NMDA receptor, is known to play a central role in several acute and chronic neurodegenerative conditions that impair learning and memory. (Thu, 03 Aug 2006 15:04:18 GMT)
WSU nabs $500K grant for cell study
Wright State University Boonshoft School of Medicine has received a $500,000 grant for science research. (Thu, 03 Aug 2006 15:07:24 GMT)
Power3 Chairman/CEO Steven Rash to be Back on MN1.com Radio Monday to Discuss Early Detection Blood Tests for Breast
HOUSTON----Aug. 3, 2006--Steven Rash, chairman and CEO of Power3 Medical Products, Inc. , will be back on Market News First radio on Monday morning, August 7, at 9:30 a.m. CDT to discuss his company's progress in blood-based early detection testing for breast cancer and neurodegenerative diseases. (Thu, 03 Aug 2006 15:43:00 GMT)
Information Systems for Biotechnology (ISB) News Report August 2006
Perennial ryegrass ( Lolium perenne L.) is the most important pasture grass for meat, dairy and wool production in New Zealand, covering more than seven million hectares (Siegal et al., 1985). It is an out-crossing, wind pollinated and highly self-incompatible species and, for these reasons, the pace of genetic improvement has been slow through conventional breeding methods. (Thu, 03 Aug 2006 16:15:24 GMT)
The Center of Nutrigenomics of the TU Munich licences Genomatix' Microarray Analysis Pipeline
Genomatix Software GmbH and the The Center of Nutrigenomics of the Technical University Munich signed a multi-year license agreement, giving the Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline. (Thu, 03 Aug 2006 17:20:11 GMT)
Report: New test for breast cancer
An international research group led by Professor Jasminka Godovac-Zimmermann, UCL Medicine, has developed an ultra-sensitive blood test for breast cancer that could help to detect cancer at a very early stage and improve screening for the disease in younger women, for whom mammography is less sensitive. (Thu, 03 Aug 2006 18:39:42 GMT)
Strategic Diagnostics Reports Second Quarter 2006 Results
NEWARK, Del.----Aug. 3, 2006--Strategic Diagnostics Inc. - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today reported financial results for the second quarter ended June 30, 2006. (Thu, 03 Aug 2006 20:19:00 GMT)
Stratagene Announces Second Quarter 2006 Earnings Release Date and Conference Call
LA JOLLA, Calif.----Aug. 3, 2006--Stratagene Corporation , today announced that it will release second quarter financial results on Tuesday, August 8, 2006 after the market close. The Company will also host a conference call and webcast on Tuesday, August 8, 2006 at 1:30 p.m. (Thu, 03 Aug 2006 20:19:00 GMT)
Invitrogen Announces Second Quarter 2006 Results
CARLSBAD, Calif.----Aug. 3, 2006--Invitrogen Corporation today announced results for its second quarter ended June 30, 2006. Revenues for the second quarter were $314 million, an increase of 2% over the $306 million reported for the second quarter of 2005. (Thu, 03 Aug 2006 20:21:00 GMT)
DNA to the defense
CAMBRIDGE, U.K., Fri., Aug 4, 2006 -- A team of scientists headed by Dr. Sara Melville at the University of Cambridge has shown that the parasite known to cause African sleeping sickness has evolved an unusual chromosomal structure as a result of environmental adaptation. (Thu, 03 Aug 2006 21:14:04 GMT)
Invitrogen profit rises, sales miss expectations
SAN FRANCISCO (MarketWatch) -- Shares of Invitrogen Corp. slumped 11.5% in late trade Thursday after the company posted a higher second-quarter profit but revenue that missed Wall Street's expectations. (Thu, 03 Aug 2006 21:39:49 GMT)
GeneLogic genomics unit slides
GeneLogic Inc. continues to report trouble in its genomics division, once the Gaithersburg company’s driving force. Most recently, GeneLogic said Tuesday it is cutting 80 jobs in the division and related administrative staff, effective Oct. 5. (Fri, 04 Aug 2006 00:36:44 GMT)
Researchers Identify Gene As Protector Of DNA, Enemy Of Tumors
A single gene plays a pivotal role launching two DNA damage detection and repair pathways in the human genome, suggesting that it functions as a previously unidentified tumor suppressor gene, researchers at the University of Texas M. D. Anderson Cancer Center report in Cancer Cell. (Fri, 04 Aug 2006 04:09:27 GMT)
UNC may decide in fall on cleaning changes
As they continue their review of a controversial proposal to change the way housekeepers clean at the university, UNC officials expect to decide this fall on whether to implement the changes. (Fri, 04 Aug 2006 04:18:27 GMT)
Church Hopes to Make DNA Decoding Accessible
George Church shows off the machines that analyze DNA sequences. He hopes to significantly reduce the cost of sequencing human DNA. George M. Church wasted no time in revolutionizing the study of genetics. (Fri, 04 Aug 2006 06:08:48 GMT)
Medal of Honour for Dundee scientist
Professor Angus Lamond of the College of Life Sciences at the University of Dundee has been awarded the prestigious Medal of Honour from the First Medical Faculty of the Charles University Prague, in recognition of his innovative use of proteomics in the study of cell biology. (Fri, 04 Aug 2006 09:23:06 GMT)
Human Tissue Generation Research To Move Forward with $1.6 Million Gift
Imagine swallowing a pill that could help heal a spinal injury or restore degenerating eyesight. Imagine applying a "smart bandage" to regenerate an amputated finger or the tissue of an unsightly wound, rather than undergoing reconstructive surgery. Sounds like science fiction. But drugs like these could be closer to reality than you think, thanks to the research by scientists of the IU Center (Fri, 04 Aug 2006 10:15:23 GMT)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug
DNAPrint Genomics, Inc. today announced that KBI BioPharma, Inc., has completed and validated a second analytical method for PT-401, based on SDS-PAGE, a well established separation technique that will be used for in-process analysis, release and stability testing for its PT-401 anemia drug, which is being developed by its subsidiary, DNAPrint Pharmaceuticals, Inc. (Fri, 04 Aug 2006 11:00:00 GMT)
Gene Logic Reports Second Quarter 2006 Financial Results
GAITHERSBURG, Md.----Aug. 4, 2006--Gene Logic Inc. today reported financial results for the second quarter ended June 30, 2006. Revenue Three Months Ended Six Months Ended June 30, 2006 June 30, 2006 ---------------------- ---------------------- % % 2006 2005 Change 2006 2005 Change ------- ------- ------ ------- ------- ------ Genomics Division $ 4,683 $14,166 -67% $13,431 $27,405 -51% (Fri, 04 Aug 2006 11:00:00 GMT)
Gene Logic's Q2 Revenue Falls 44 Percent on Weak Genomics Results
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click . (Fri, 04 Aug 2006 14:05:46 GMT)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that KBI BioPharma, Inc., has completed and validated a secondanalytical method for PT-401, based on SDS-PAGE, a well establishedseparation technique that will be used for in-process analysis, release andstability testing for its PT-401 anemia drug, which is being developed byits subsidiary, DNAPrint Pharmaceuticals, Inc. (Fri, 04 Aug 2006 15:50:26 GMT)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug
DNAPrint Genomics, Inc. (OTCBB: DNAG) today an (Fri, 04 Aug 2006 16:07:59 GMT)
Invitrogen slumps on revenue miss, lowered forecast
SAN FRANCISCO (MarketWatch) -- Invitrogen Corp. shares fell to their lowest point in nearly two years Friday, retreating after the company posted second-quarter revenue that missed Wall Street's expectations and cut its full-year forecast. (Fri, 04 Aug 2006 16:24:58 GMT)
Applied Biosystems And GeneGo Collaborate To Advance Understanding Of Tissue Gene Expression
Applied Biosystems, an Applera Corporation business, and GeneGo, Inc., a provider of software and databases for systems biology, announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways (Fri, 04 Aug 2006 17:10:53 GMT)
Ciphergen Biosystems, Inc. Announces Issuance of 2nd Quarter 2006 Financial Results and Events
Ciphergen Biosystems, Inc. , will announce 2nd Quarter 2006 Financial Results and Events on Monday, August 14, 2006 after market close. (Fri, 04 Aug 2006 18:26:00 GMT)
Researchers identify how molecules of microRNA are responsible for the growth of blood vessels in a model for human
The process, called angiogenesis, results in ability of ravenous cancer cells to recruit blood vessels and receive a steady supply of nutrients and oxygen. (Fri, 04 Aug 2006 20:51:53 GMT)
Human embryonic stem cells display a unique pattern of chemical modification to DNA
San Diego, Calif. -- Scientists from the Burnham Institute for Medical Research (BIMR) and Illumina Inc., in collaboration with stem cell researchers around the world, have found that the DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern. (Fri, 04 Aug 2006 21:08:38 GMT)
With Indonesia's say so, WHO to share bird flu data with scientific community
(CP) - The World Health Organization on Friday welcomed the announcement that the Indonesian government had agreed to share with the global scientific community the genetic blueprints of the H5N1 avian flu viruses retrieved from human cases in that country. (Fri, 04 Aug 2006 21:26:00 GMT)
Sequencing The Genome Of A New Kind Of Methane Producer
Max Planck researchers uncover the survival strategy of microorganisms responsible for the worldwide emission of methane from rice paddies. (Fri, 04 Aug 2006 22:10:08 GMT)
Galapagos and AstraZeneca enter drug discovery collaboration
Genomics-based drug company Galapagos has entered into a new drug discovery collaboration with AstraZeneca focusing on respiratory and inflammatory drugs. (Sat, 05 Aug 2006 01:06:43 GMT)
Quantum Information Research Could Transform The Power Of Computing
Although presently a very young field, Quantum Information Science and Technology (QIST) could well have a vital role to play in future information and communication technologies. Quantum computing and communication techniques have the potential to transform the way we think about computing power. (Sat, 05 Aug 2006 04:09:27 GMT)
The Center Of Nutrigenomics Of The TU Munich Licences Genomatix Microarray Analysis Pipeline
Genomatix Software GmbH and the The Center of Nutrigenomics of the Technical University Munich signed a multi-year license agreement, giving the Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.The Center of Nutrigenomics of the Technical University Munich headed by Prof. Hannelore Daniel is a leading institution of nutrition research. [click link for full (Sat, 05 Aug 2006 09:15:45 GMT)
Device Could Do 'Battle' With Hospital Infections
An innovative University at Buffalo air sterilization technology that the U.S. Department of Defense is funding to protect troops on the battlefield soon may be protecting hospital patients from deadly infections, thanks to recent funding from the New York State Office of Science, Technology and Academic Research (NYSTAR). (Sat, 05 Aug 2006 16:10:07 GMT)
DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern
Embryonic stem cells are derived from embryos that are undergoing a period of intense cellular activity, including the chemical addition of methyl groups to specific DNA sequences in a process known as DNA methylation. (Sun, 06 Aug 2006 04:51:42 GMT)
Genetic breakthroughs usher in personalized medicine
Matthew Green shaves, does his own laundry and can cook. He wiped down tables at the Beverly Hills Cafe in his hometown of Pembroke Pines until recently. (Sun, 06 Aug 2006 05:08:35 GMT)
PM to visit Helsinki for India-EU summit in Oct
Prime Minister Manmohan Singh will meet his Finnish counterpart Matti Vanhanen in Helsinki for the seventh India-EU summit on October 13 during which the two sides are expected to discuss a range of issues including fight against terrorism and cooperation in scientific research and technology Finland holds the 25-nation European Union's rotating presidency until the end of this year. (Sun, 06 Aug 2006 09:03:42 GMT)
A chip off the auld sod
This is a story about finding lost loved ones. (Sun, 06 Aug 2006 10:36:06 GMT)
Neural Stem Cells Derived From Human Embryonic Stem Cells Carry Abnormal Gene Expression
Neural stem cells grown from one of the federally approved human embryonic stem cell lines proved to be inferior to neural stem cells derived from fetal tissue donated for research, a UCLA study has found. (Sun, 06 Aug 2006 12:54:57 GMT)
Water cooler
What's the latest and greatest news heard around the water cooler? (Sun, 06 Aug 2006 15:49:07 GMT)
Family carries out vision for property
The first segment of developer John F. Long's 1,000-acre Algodón Center is aimed at forming a medical hub along Loop 101, a transportation corridor fast emerging as the West Valley's sports, entertainment and job center. (Mon, 07 Aug 2006 02:24:10 GMT)
Scientists discover milk's healing power
Milk's ability to keep teeth white and bones strong is well known but its benefits could extend to treating gut inflammation and helping skin repair. (Mon, 07 Aug 2006 06:15:09 GMT)
Scientists see healing power in milk
MILK'S ability to keep teeth white and bones strong is well known but its benefits could extend to treating gut inflammation and helping skin repair. (Mon, 07 Aug 2006 06:18:03 GMT)
Scientists discover milk's healing power
Milk's ability to keep teeth white and bones strong is well known but its benefits could extend to treating gut inflammation and helping skin repair. - (Mon, 07 Aug 2006 06:34:18 GMT)
StockCar stocks
If you want a broad stock portfolio in a single mutual fund, you might buy a plain-vanilla Standard & Poor's 500 index fund. But if you'd like something quirkier, with more horsepower and much more torque, you might prefer the StockCar Stocks Index fund. (Mon, 07 Aug 2006 07:17:34 GMT)
Technology growth is expected to boost the drug discovery industry for Europe
The drug discovery industry has become such a competitive market that it continually faces a challenge to find better drug discovery technologies. (Mon, 07 Aug 2006 08:34:38 GMT)
VASTox PROVIDES GRANT TO SUPPORT DUCHENNE MUSCULAR DYSTROPHY PATIENT REGISTRY
The DMD Registry aims to register every person in the UK with DMD and Becker muscular dystrophy, including detailed clinical and genetic data, in a secure, legally protected database that has been endorsed by senior clinicians, health professionals and researchers. (Mon, 07 Aug 2006 09:44:38 GMT)
The Australian Genome Research Facility Joins CombiMatrix CombiCore(TM) Access Program
NEWPORT BEACH, Calif.----Aug. 7, 2006--Acacia Research Corporation announced today that its CombiMatrix group has signed a non-exclusive agreement with the Australian Genome Research Facility under the company's CombiCore access program. (Mon, 07 Aug 2006 10:00:00 GMT)
BioStorage Technologies Secures $5 Million Series A Financing Led by Radius Ventures and Appoints George M. Milne, Jr.,
BioStorage Technologies, Inc. a premier provider of advanced biomaterial storage, inventory management and cold chain logistics for the global biopharmaceutical market, today announced that it has secured a $5 million Series A financing led by Radius Ventures and joined by returning investor Twilight Venture Partners. (Mon, 07 Aug 2006 11:28:00 GMT)
Relative Genetics' Easy, Inexpensive DNA Tests Generate Ancestry Answers for Family History Hobbyists
SALT LAKE CITY----Aug. 7, 2006--Relative Genetics Once Stymied by Missing Family History Resources, an Army Physician Who Retired to Arizona and a California Writer Learn Definitively Who Their Extended Family is by Having Their Own DNA Tested. (Mon, 07 Aug 2006 11:30:00 GMT)
Nanogen to Host Second Quarter Conference Call and Webcast on August 9, 2006
Nanogen, Inc. , developer of advanced diagnostic products, will host a conference call on Wednesday, August 9, 2006 at 4:30 p.m. Eastern to discuss 2006 second quarter financial results. (Mon, 07 Aug 2006 12:00:00 GMT)
Clinical Data Appoints New CFO
NEWTON, Mass.----Aug. 7, 2006--Clinical Data, Inc. today named C. Evan Ballantyne as Senior Vice President and Chief Financial Officer. Ballantyne replaces Israel M. Stein, M.D., who had most recently served as the Company's interim chief financial officer. (Mon, 07 Aug 2006 12:00:00 GMT)
NIH Seeks to Out-License Protein Microarray Technology
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click . (Mon, 07 Aug 2006 13:35:40 GMT)
Wine researchers seek scientific answers to ancient headaches
MOUNTAIN GROVE, Mo. (AP) - Every growing season, wine makers fight the same battles to protect their grapevines that they have faced for thousands of years. From ancient Mesopotamia to today's vineyards, the eternal enemies include fungus and bugs, extreme heat and unseasonable cold. (Mon, 07 Aug 2006 13:40:54 GMT)
Affymetrix: Price Always Matters
When I wrote about Affymetrix (Nasdaq: AFFX) a year ago and suggested that the stock was too expensive and that the company had more competition than some people might realize, you would have thought I'd shot the Easter Bunny and made it into hasenpfeffer. (Mon, 07 Aug 2006 14:09:26 GMT)
Farm & Ranch Guide
North Dakota State University and Monsanto have announced a collaboration between the NDSU AgBiotechnology: Oilseed Development Center of Excellence and the St. Louis-based agricultural company. (Mon, 07 Aug 2006 15:41:42 GMT)
Nanogen to Host Second Quarter Conference Call and Webcast on August 9, 2006
Nanogen, Inc. , developer of advanced diagnostic products, will host a conference call on Wednesday, August 9, 2006 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2006 second quarter financial results. The financial results press release will be issued at close of market on August 9. Interested investors and others may participate in the conference call by dialing (877) 407-9205 for (Mon, 07 Aug 2006 16:21:12 GMT)
Scientists Reverse Evolution: Ancient Gene Reconstructed From Descendants
University of Utah scientists have shown how evolution works by reversing the process, reconstructing a 530-million-year-old gene by combining key portions of two modern mouse genes that descended from the archaic gene. (Mon, 07 Aug 2006 16:25:07 GMT)
'Rule-of-Five' Author Christopher Lipinski Joins Advisory Board of FlexX Developer BioSolveIT
SANKT AUGUSTIN, Germany----Aug. 7, 2006--BioSolveIT, known for its high impact drug design software, has succeeded in winning renowned scientist Christopher A. Lipinski for its Scientific Advisory Board. (Mon, 07 Aug 2006 16:26:00 GMT)
BioStorage Technologies Secures $5 Million Series A Financing Led By Radius Ventures and Appoints George M. Milne, Jr.,
INDIANAPOLIS, Aug. 7 /PRNewswire/ -- BioStorage Technologies, Inc. (Mon, 07 Aug 2006 16:27:01 GMT)
Clinical Data Appoints New CFO
Clinical Data, Inc. (NASDAQ: CLDA) today named C. Evan Ballantyne as Senior Vice President and Chief Financial Officer. Ballantyne replaces Israel M. Stein, M.D., who had most recently served as the Company's interim chief financial officer. (Mon, 07 Aug 2006 16:27:33 GMT)
Celera makes good on human genome project
In 2001, Celera Genomics (Rockville, MD) rocked the scientific community by publishing its findings of the human genome sequence. It appears Celera is seeing the fruits of its labor with the discovery of genetic markers that could be developed into clinical IVDs. (Mon, 07 Aug 2006 17:35:16 GMT)
Acting FDA Commissioner to Provide an Overview on the FDA's Initiatives for Protecting and Advancing Public Health
Acting FDA Commissioner, Andrew C. von Eschenbach, M.D. will deliver a keynote address on Wednesday, August 9th at IBC's 11th Annual Drug Discovery Technology(R) & Development World Congress. The congress, taking place on August 7-10, 2006 at the World Trade Center in Boston, features over 200 speakers, 6 dedicated conferences and more than 300 booths on the exhibit hall floor, which opens on (Mon, 07 Aug 2006 18:36:32 GMT)
QIAGEN Reports Strong Second Quarter 2006 Results
QIAGEN N.V. today announced the results of operations for the second quarter and the six-month period ended June 30, 2006. (Mon, 07 Aug 2006 20:00:00 GMT)
QIAGEN Reports Strong Second Quarter 2006 Results
VENLO, The Netherlands, August 7 /PRNewswire-FirstCall/ -- QIAGEN ( Nachrichten / Aktienkurs ) N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced the results of operations for the second quarter and the six-month period ended June 30, 2006. (Mon, 07 Aug 2006 20:10:53 GMT)
Hunt for DNA Amplified in Cancers Uncovers Important Target Gene
Researchers at Harvard Medical School (HMS) and Massachusetts General Hospital (MGH) have discovered a new cancer-promoting role for a gene potentially involved in breast, liver, and other kinds of cancers. Their discovery that the gene YAP can transform mammary epithelial cells opens the door to understanding how a novel cell growth controlling pathway first discovered in fruit flies might be (Mon, 07 Aug 2006 21:15:52 GMT)
Stanford Hosts National Bioinformatics Conference Aug. 14-18
Want to know how scientists are using the power of computers to devise new ways of diagnosing and treating disease? You can ask the nation's top experts during an Aug. 15 panel discussion at Stanford University. (Mon, 07 Aug 2006 22:17:16 GMT)
Cellphones decoded
It's still a big unknown if cellphones are a potential health hazard, but a new study is convinced about one aspect: Effects of cellphone radiation could vary from person to person, depending on a user’s genes. (Tue, 08 Aug 2006 00:57:36 GMT)
Technique Used Commonly In Physics Finds Application In Neuroscience
To understand how brain cells release compounds (or transmitters) used when the cells communicate with each other, Vladimir Parpura, associate professor of neuroscience, and Umar Mohideen, professor of physics, devised a new technique, used commonly in physics, that can be applied now to the study of a wide range of biological processes and interactions. [click link for full article] (Tue, 08 Aug 2006 02:15:44 GMT)
Informatics Researchers Throttle Notion Of Search Engine Dominance
Search engines are not biased toward popular Web sites, and may even be egalitarian in the way they direct traffic, say Indiana University School of Informatics researchers. (Tue, 08 Aug 2006 04:09:28 GMT)
Loosen Up, DNA: Leukemia Gene Changes Genetic Packaging
A signaling system involved in many forms of leukemia and lymphoma is more powerful than scientists have thought, exerting control over our genes by affecting whole swaths of chromosomes in global fashion. The findings come from a study where mutant fruit flies with either red or white eyes tell the tale of a cellular signaling system known as JAK/STAT. The finding meshes nicely with current (Tue, 08 Aug 2006 04:09:38 GMT)
Finding Challenges Scientists' General View Of How A Chromosome Is Functionally Organized
A team of scientists headed by Dr. Sara Melville at the University of Cambridge has shown that the parasite known to cause African sleeping sickness has evolved an unusual chromosomal structure as a result of environmental adaptation. [click link for full article] (Tue, 08 Aug 2006 04:15:44 GMT)
GenoMed's First Horse Recovers Quickly From Presumed West Nile Virus Encephalitis
GenoMed (OTC Pink Sheets GMED), a Next Generation Disease Management company that uses genomics to solve diseases in as many species as possible, today announced that the first horse in its expanded trial for West Nile virus encephalitis recovered completely within 24 hours after starting GenoMed's treatment. [click link for full article] (Tue, 08 Aug 2006 07:17:25 GMT)
Gene amplification links growth controlling pathway from Drosophila to human cancers
Researchers at Harvard Medical School (HMS) and Massachusetts General Hospital (MGH) have discovered a new cancer-promoting role for a gene potentially involved in breast, liver, and other kinds of cancers. (Tue, 08 Aug 2006 09:52:13 GMT)
EcoArray Announces New Technology for Environmental Testing
EcoArray, Inc. announced today the release of its 22,000-gene microarray in Fathead minnows designed for research and use in environmental toxicology. (Tue, 08 Aug 2006 10:00:00 GMT)
Metal Homeostasis Research In Plants Will Lead To Nutrient-rich Food And Higher Yielding Crops
Deficiencies of micronutrients such as iron and zinc commonly limit plant growth and crop yields. Dartmouth professor Mary Lou Guerinot is conducting research to better understand the mechanisms of micronutrient uptake, distribution and regulation. Guerinot's findings are making it feasible to engineer nutrient-rich plants better able to grow in soils now considered marginal and to increase crop (Tue, 08 Aug 2006 10:09:27 GMT)
Fly Genetics Reveal Key Workings Of Atkins Diet
Metabolic syndrome, an aging-associated group of disorders that includes insulin resistance, heart disease and high lipid levels, may be treatable thanks to a newly discovered role for a regulatory gene, according to a team of scientists at the Burnham Institute for Medical Research. (Tue, 08 Aug 2006 10:09:57 GMT)
Human Embryonic Stem Cells Display A Unique Pattern Of Chemical Modification To DNA
Scientists from the Burnham Institute for Medical Research (BIMR) and Illumina Inc., in collaboration with stem cell researchers around the world, have found that the DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern. This pattern distinguishes human embryonic stem cells from normal adult cells and cell lines, including cancer cells. [click link for (Tue, 08 Aug 2006 10:15:45 GMT)
DNAPrint Genomics Engages Harvard Physician and Scientist as Consultant to Company
DNAPrint Genomics, Inc. today announced that Dr. Arthur Sytkowski, the Director of the Laboratory for Cell and Molecular Biology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, will continue as a consultant for the Company on scientific, medical, regulatory and patent issues. (Tue, 08 Aug 2006 11:00:00 GMT)
JMP(R) Genomics Software from SAS Achieves GeneChip-compatible(TM) Status
BOSTON----Aug. 8, 2006--SAS, the leader in business intelligence, today announced that two products in its suite of genomics software, JMP Microarray and JMP Genetics, earned GeneChip-compatible status for use with the Affymetrix microarray platform. (Tue, 08 Aug 2006 12:00:00 GMT)
GeneGo is Awarded Phase II SBIR Grant for Systems Proteomics Platform
GeneGo, Inc., a leading provider of databases, software and services in systems biology, announced today that they have received a $750,000 Phase II SBIR grant from the Department of Defense for the development of a systems biology suite for functional analysis of proteomics data. (Tue, 08 Aug 2006 12:00:00 GMT)
Clinical Data to Present at Drug Discovery Technology
NEWTON, Mass.----Aug. 8, 2006--Clinical Data, Inc. today announced that two of its researchers will independently present at the upcoming Drug Discovery Technology and Development 11th Annual World Congress in Boston, Mass. (Tue, 08 Aug 2006 12:00:00 GMT)
Wine researchers seek scientific answers to ancient headaches
MOUNTAIN GROVE, Mo. (AP) - Every growing season, wine makers fight the same battles to protect their grapevines that they have faced for thousands of years. From ancient Mesopotamia to today's vineyards, the eternal enemies include fungus and bugs, extreme heat and unseasonable cold. (Tue, 08 Aug 2006 12:10:09 GMT)
BioMachines Inc Adopt Nonlinear Dynamics' SameSpots Approach for 2D Image Analysis
NEWCASTLE UPON TYNE, England----Aug. 8, 2006--Nonlinear Dynamics Ltd, a leading global provider of bioinformatics solutions, today announced that BioMachines Inc. have selected SameSpots as the 2D analysis solution to support their new state-of-the-art protein analysis service. (Tue, 08 Aug 2006 12:13:00 GMT)
EcoArray Announces New Technology for Environmental Testing
ALACHUA, Fla., Aug. 8 /PRNewswire/ -- EcoArray, Inc. announced today the release of its 22,000-gene microarray in Fathead minnows designed for research and use in environmental toxicology. The array is available immediately. (Tue, 08 Aug 2006 12:33:06 GMT)
Hunt For DNA Amplified In Cancers Uncovers Important Target Gene
Researchers at Harvard Medical School (HMS) and Massachusetts General Hospital (MGH) have discovered a new cancer-promoting role for a gene potentially involved in breast, liver, and other kinds of cancers (Tue, 08 Aug 2006 13:40:43 GMT)
MatBase -- A new transcription factor knowledge base released by Genomatix
Munich (Germany) , August 8, 2006 -- Genomatix Software GmbH, a pioneer and leader in the analysis of eukaryotic transcriptional regulation, releases MatBase, a knowledge base of transcription factors (TF). (Tue, 08 Aug 2006 13:43:43 GMT)
GeneGo Wins $750K DoD SBIR Grant to Develop Systems Bio Proteomics Tech
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click . (Tue, 08 Aug 2006 13:51:00 GMT)
BioMachines' New Proteomics Services Arm Will Use Nonlinear Dynamics' 2D-Analysis Tech
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click . (Tue, 08 Aug 2006 13:51:10 GMT)
Expression Analysis Announces Limited 2006 First Half Financial Results
DURHAM, N.C.----Aug. 8, 2006--Expression Analysis, Inc., a full-service microarray processing, analysis and data management organization, has announced limited financial results for the first half of 2006 today. (Tue, 08 Aug 2006 14:00:00 GMT)
Invitrogen upgraded to "buy"
NEW YORK, August 8 (newratings.com) - Analyst Frank Pinkerton of Banc of America Securities upgrades Invitrogen Corporation ( IVGN.NAS ) from "neutral" to "buy," while reducing his estimates for the company. The target price has been reduced from $76 to $70. (Tue, 08 Aug 2006 14:25:55 GMT)
Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company
HANNOVER, Germany----Aug. 8, 2006--Digilab BioVisioN and Novartis will continue and expand their cooperation in the field of biomarker discovery in drug treatment studies. Digilab BioVisioN announced the closure of a new agreement applying their Peptidomics® technology in the quantitative characterization of the peptides in biological samples with the aim to discover potential biomarkers. (Tue, 08 Aug 2006 15:05:00 GMT)
1 2 3 4 5 Next
